Sugi Predict

Sugi Predict / Compounds / SCHEMBL4186574

SCHEMBL4186574

SCHEMBL4186574

CCCn1c(=O)c2c(nc(Cc3ccccc3)n2CCNCC(O)CC)n(CCc2cccc(NC(=O)C(CC(=O)O)NC(=O)CCCCCN)c2)c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 1/20 0.35
▸ ADORA2B P29275 1/20 0.35
▸ SIRT2 Q8IXJ6 1/20 0.34
▸ SIRT1 Q96EB6 1/20 0.34
▸ SIRT3 Q9NTG7 1/20 0.34
▸ CHRNB2 P17787 2/20 0.34
▸ CHRNB4 P30926 2/20 0.34
▸ CHRNA3 P32297 2/20 0.34
▸ CHRNA4 P43681 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ MAPT P10636 3/20 0.33
▸ TP53 P04637 1/20 0.33
▸ ITGB3 P05106 1/20 0.33
▸ ITGA2B P08514 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ MMP2 P08253 3/20 0.32
▸ GHSR Q92847 1/20 0.32
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4172631 0.99 ADORA2A (0.35) ADORA2AADORA2BSIRT2SIRT1SIRT3
SCHEMBL4165128 0.95 CHRNB2 (0.36) ADORA2AADORA2BCHRNB2CHRNB4CHRNA3
SCHEMBL4180241 0.95 CHRNB2 (0.36) ADORA2AADORA2BCHRNB2CHRNB4CHRNA3
SCHEMBL4189331 0.94 ADORA2A (0.35) ADORA2AADORA2BSIRT2SIRT1SIRT3
SCHEMBL4186030 0.94 ADORA2A (0.36) ADORA2AADORA2BSIRT2SIRT1SIRT3
SCHEMBL4169858 0.93 ADORA2A (0.37) ADORA2AADORA2BSIRT2SIRT1SIRT3
SCHEMBL4172399 0.93 ADORA2A (0.34) ADORA2AADORA2BSIRT2SIRT1SIRT3
SCHEMBL4182201 0.92 MAPT (0.38) ADORA2AADORA2BTSHRMAPTTP53
SCHEMBL4186015 0.92 CHRNB2 (0.36) ADORA2AADORA2BCHRNB2CHRNB4CHRNA3
SCHEMBL4184661 0.91 CHRNB2 (0.36) ADORA2AADORA2BCHRNB2CHRNB4CHRNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090068101-A9 A1 Adenosine Receptor Antagonists ENDACEA, INC. (US) 2009-03-12 — — US disclosed
US-20070274910-A1 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility ENDACEA, INC. (US) 2007-11-29 — — US disclosed
EP-1636230-A2 A1 ADENOSINE RECEPTOR ANTAGONISTS Endacea, Inc. (US) 2006-03-22 — — EP disclosed
WO-2004110379-A2 A1 ADENOSINE RECEPTOR ANTAGONISTS ENDACEA, INC. (US) 2004-12-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070274910-A1 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility HRH3, HRH1, HRH2 ADORA2A 7/4885ADORA2B 9/4885SIRT2 3967/4885
US-20090068101-A9 A1 Adenosine Receptor Antagonists ADORA1, ADORA3, ADORA2A ADORA2A 3/4885ADORA2B 4/4885SIRT2 2924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.